English | Español
Carol Ostrow | Jan 2, 2017

American Cancer Society lists 2016’s impact drugs
Ruth de Jauregui | Dec 29, 2016

Michael J. Fox Foundation reviews successes of 2016
Jeff Gantt | Dec 28, 2016

Study reveals high pain tolerance could mask heart attacks
Keri Carbaugh | Dec 27, 2016

Research accelerated for improved TB tests, vaccines
Keri Carbaugh | Dec 27, 2016

Shionogi & Co., Purdue Pharma launch commercial plan for naldemedine
Jeff Gantt | Dec 24, 2016

Pfizer releases Paloma-2 sub-analysis study data
Jeff Gantt | Dec 24, 2016

EMA recommends Keytruda for approval
Jeff Gantt | Dec 23, 2016

Keytruda approved in Japan to treat lung cancer

Trending
+ Regulatory
C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'